etidronate and dinoprostone

etidronate has been researched along with dinoprostone in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (75.00)	18.2507
2000's	2 (16.67)	29.6817
2010's	1 (8.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Jee, WS; Ke, HZ; Kimmel, DB; Tang, LY	1
Jee, WS; Ke, HZ; Lin, BY; Ma, YF	1
Huang, LF; Jee, WS; Ke, HZ; Li, QN; Liang, NC; Ma, YF; Xie, H	1
Chen, YY; Ijiri, K; Jee, WS; Ke, HZ; Ma, Y	1
Chen, HK; Jee, WS; Li, XJ; Ma, YF; McOsker, JE; Pan, Z	1
Jee, WS; Li, XJ; Ma, YF; McOsker, JE; Pan, Z	1
Jee, WS; Li, XJ; Liang, HH; Ma, YF; McOsker, JE; Pan, Z; Setterberg, RB	1
Chen, YY; Jee, WS; Ke, HZ; Li, XJ; Lin, BY; Lin, CH; Ma, YF	1
Chen, H; Jee, WS; Li, XJ; Liang, HH; Lin, CH; Ma, YF; Pan, Z; Pun, S	1
Appleman, S; Keelan, M; Thomson, AB; Wallace, JL	1
Fujishiro, T; Hashimoto, S; Hasuda, K; Hayashi, S; Kurosaka, M; Niikura, T; Nishiyama, T; Suzuki, Y	1

Trials

1 trial(s) available for etidronate and dinoprostone

Article	Year
Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa. Digestive diseases and sciences, 2003, Volume: 48, Issue:2 Topics: Administration, Oral; Aged; Alendronate; Biomarkers; Biopsy, Needle; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Drug Administration Schedule; Etidronic Acid; Female; Gastric Juice; Gastric Mucosa; Gastroscopy; Humans; Interleukin-1; Interleukin-13; Interleukin-8; Middle Aged; Postmenopause; Reference Values; Risedronic Acid; Sensitivity and Specificity; Single-Blind Method	2003

Article

Year

Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa.

Digestive diseases and sciences, 2003, Volume: 48, Issue:2

Topics: Administration, Oral; Aged; Alendronate; Biomarkers; Biopsy, Needle; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Drug Administration Schedule; Etidronic Acid; Female; Gastric Juice; Gastric Mucosa; Gastroscopy; Humans; Interleukin-1; Interleukin-13; Interleukin-8; Middle Aged; Postmenopause; Reference Values; Risedronic Acid; Sensitivity and Specificity; Single-Blind Method

2003

Other Studies

11 other study(ies) available for etidronate and dinoprostone

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1992, Volume: 7, Issue:9 Topics: Aging; Animals; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Dinoprostone; Etidronic Acid; Female; Ovariectomy; Rats; Rats, Sprague-Dawley; Risedronic Acid	1992
Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1995, Volume: 10, Issue:6 Topics: Aging; Analysis of Variance; Animals; Body Weight; Bone Development; Bone Resorption; Calcium Channel Blockers; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Muscle, Skeletal; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia	1995
Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats. Bone, 1995, Volume: 17, Issue:4 Suppl Topics: Aging; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Interactions; Etidronic Acid; Female; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Reference Values; Risedronic Acid; Tibia	1995
Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. Bone, 1995, Volume: 17, Issue:4 Suppl Topics: Aging; Animals; Body Weight; Bone Development; Bone Diseases, Metabolic; Dinoprostone; Drug Therapy, Combination; Etidronic Acid; Factor Analysis, Statistical; Female; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Risedronic Acid	1995
Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats. Bone, 1995, Volume: 17, Issue:4 Suppl Topics: Analysis of Variance; Animals; Dinoprostone; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia	1995
Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats. Bone, 1995, Volume: 17, Issue:4 Suppl Topics: Animals; Bone Development; Bone Marrow; Dinoprostone; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia	1995
Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats. Bone, 1995, Volume: 17, Issue:4 Suppl Topics: Analysis of Variance; Animals; Bone Diseases, Metabolic; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Etidronic Acid; Female; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia	1995
Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:2 Topics: Age Factors; Aging; Animals; Bone and Bones; Bone Density; Calcium Channel Blockers; Dinoprostone; Drug Synergism; Drug Therapy, Combination; Etidronic Acid; Female; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia	1997
Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:12 Topics: Animals; Bone and Bones; Bone Density; Bone Remodeling; Calcium Channel Blockers; Dinoprostone; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Osteoporosis; Ovariectomy; Ovary; Oxytocics; Rats; Rats, Sprague-Dawley; Risedronic Acid; Time Factors; Weight Gain	1997
Effect of etidronate on COX-2 expression and PGE(2) production in macrophage-like RAW 264.7 cells stimulated by titanium particles. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2007, Volume: 12, Issue:6 Topics: Animals; Bone Resorption; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Etidronic Acid; Gene Expression; Interleukin-1beta; Interleukin-6; Macrophages; Mice; Nitrobenzenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Titanium; Tumor Necrosis Factor-alpha	2007